Switzerland buying marijuana

__________________________

📍 Verified store!

📍 Guarantees! Quality! Reviews!

__________________________

▼▼ ▼▼ ▼▼ ▼▼ ▼▼ ▼▼ ▼▼

▲▲ ▲▲ ▲▲ ▲▲ ▲▲ ▲▲ ▲▲

Switzerland buying marijuana

The situation of the hemp industry in different parts of the world certainly depends on the politics in a country and the favorability of the authorities to the subject of hemp. This is the highest limit in Europe; most countries have it set at 0. However, there is a definite difference for farmers and entrepreneurs, as they are less likely to exceed the THC content of their products, which does not expose them to legal problems. Possession of raw material that has more of it is punishable by a fine of francs about zlotys , as long as the person is carrying more than 10 grams. Possession of smaller amounts exposes a person to a warning at most. They are then not qualified as a drug, but are subject to regulations under which a hemp product is marketed. This applies to medicinal products, foodstuffs, cosmetics, or chemicals. The cultivation of hemp seed in Switzerland is only possible after obtaining a special permit. There must be no more THC in the plants than what is allowed by current law. The relevant cantonal enforcement authority must be notified and proof of product registration must be obtained. CBD medical products are subject to the general regulation that applies to medicinal products, which provides for a manufacturing authorization, a wholesale authorization and a marketing authorization. Foods created from seeds that do not contain CBD, for example, oil, flour, seeds or hemp infusion, can be marketed without prior authorization, as they are not covered by the regulation on novel foods. In the case of cosmetics, the addition of natural CBD as an ingredient in them is only legal if it comes from hemp seeds or leaves. Synthetic CBD is not specifically regulated and can therefore be used in cosmetic products. Legalization of the use of cannabis for medical purposes came into effect relatively recently, only in August Currently, medical cannabis is only available to patients suffering from severe medical conditions and prescribed by a doctor. Indications for use include, for example, severe chronic pain and muscle spasms. In most cases, the treatment is not reimbursed and the patient must pay for the purchase of cannabis himself. The regulatory change also allowed the export of medical cannabis for commercial purposes thanks to an authorization that companies must apply for from Swissmedic , the Swiss regulator of medicines and medical devices. Prior to the new regulations, patients using medical marijuana had to apply to the Federal Office of Public Health FOPH for approval to import the drug. Both are available by prescription only. Because they contain a high dose of psychoactive THC they are still classified as a drug, so they can only be grown, imported and sold for medical use as long as the marketer obtains a license from the Federal Office of Public Health. The procedure for obtaining it is very rigorous and involves such companies meeting a number of formal requirements. In the case of cannabis-based drugs which contain THC in their composition that have been approved for use in Switzerland, patients can only access them by prescription. The patient can — through his or her doctor — apply for a medical use permit issued by the Federal Office of Public Health. The popularity of cannabis in the food and dietary supplements market has caught the interest of the authorities, making them closely examine trends in both the legal and black markets. According to unofficial statistics, the consumption and trade of cannabis in Switzerland has been steadily increasing, which was particularly noticeable during the pandemic period. This trend contributed to the decision to introduce a pilot program for regulated cannabis trade. Its goal is to allow cities to implement pilot programs for their citizens, which include the opportunity to legally purchase marijuana at special outlets for a select group of registered participants. According to the law, there can be a maximum of five thousand in one program. With this, the authorities want to get the needed data on the effects of regular cannabis consumption and the functioning of the cannabis market. Conclusions from this research will be used, among other things, to develop methods to combat the black market and prepare a hemp law for the entire country. One of the objectives of the program is to grow hemp locally. In this way, the demand for dried hemp for program participants is to be met by local farmers, without the need to import expensive dried hemp. As a condition of participation in the program as a producer, a permit must be obtained from the Federal Bureau of Public Health. Only adults can become participants in the program, and their health status will be monitored by doctors on an ongoing basis. The first city to take advantage of the opportunity to organize the program at home was Zurich. As part of an ongoing 3. Zurich was followed by Basel, where as of mid some people can legally buy dried cannabis under the program. Switzerland has shown foresight in establishing its drug policy over the years. The reason was the failure to meet quality standards in the production of dried cannabis that was to be used for testing. The supplier of the drought, Pure, delivered the new products late. It is expected to last until The first legal dispensary opened in December and sells marijuana exclusively to program participants. Recreational marijuana is sold for between 9 and 12 Swiss francs per gram 40 — 55 zloty , depending on THC content. Vote count: 2. No votes so far! Be the first to rate this post. Your email address will not be published. Save my name, email, and website in this browser for the next time I comment. The Netherlands is associated by many with a hemp paradise. Tourists often go there to party, visiting coffee shops where The group of people who regularly consume CBD is growing. They also include celebrities, famous athletes and professional drivers, i. Despite the growing awareness of our society and the many scientific publications on hemp, we keep coming across false statements The government of Malta was the first in the European Union to decide to legalize the cultivation and possession of The appearance of hemp regulation in Slovenia is a perfect example of how strong public approval of hemp consumption is CBD oil cures cancer! CBD oil cures you of depression, neurosis and anxiety! CBD oil reverses diabetes! CBD oil for Alzheimer's! Sound familiar? Surely, more than one cannabis fan once dreamed of having real seedlings of the plant at home or in the You are here: Home » Blog » Cannabis law in Switzerland. Law 0 Comments. Last update: June 26th, min. Table of Contents. How useful was this post? Click on a star to rate it! Leave a Reply Cancel reply Your email address will not be published. Related Posts 15 Apr 15 April Read more. CBD Salve Ointment — ml 5. HempKing Sp. Please accept the files and the related processing of personal data. For more information click on the 'More information' button. Details can be found in our Privacy Policy. Accept More information.

Cannabis law in Switzerland

Switzerland buying marijuana

Under the Swiss Narcotics Act, cannabis is a prohibited narcotic drug. Depending on how often it is used and in what amount, cannabis can put the health of young people in particular at risk. As a psychoactive substance, cannabis is smoked, with or without tobacco, as marijuana dried flower heads or hashish resin from the flower heads. Rarely, it is consumed dissolved in drinks or food. Depending on its composition and dose, effects range from calming to euphorigenic to mildly hallucinogenic. Cannabis contains around chemical compounds. The psychoactive i. Other active substances cannabinoids like cannabidiol CBD are not subject to the Narcotics Act as they do not have comparable psychoactive effects. Top of page. From a public health perspective, frequent use of large amounts of cannabis over a long period is particularly problematic. Although this risk group in Switzerland is relatively small fewer than , people , these individuals are at increased risk of mental, social and physical problems as a result of cannabis use. The health risks of infrequent cannabis use are fairly low compared to other psychoactive substances, but by no means harmless. The risks are greater with long-term use starting at an early age. Long-term high-risk cannabis use increases the likelihood of mental issues such as depression, anxiety and personality disorders. Long-term cannabis use also harbours the risk of developing psychological dependence. The effect of THC impairs driving, the ability to pay attention, to concentrate and to learn. Continuous high levels of use can negatively impact performance at school or at work. Frequently smoking cannabis mixed with tobacco also increases the risk of respiratory or cardiovascular diseases. Moreover, since cannabis is illegal, there are no quality controls of the products. Thus, users are generally unaware of the THC content and may expose themselves to unknown risks. The Federal Office of Public Health, FOPH supports the cantons, communities and specialist institutions in developing and implementing measures for the prevention, early detection and intervention and treatment of addiction problems. The FOPH uses health promotion and prevention in the school setting to reach out to children and adolescents:. Through research projects , including monitoring and specific studies on cannabis consumption, the FOPH organizes the scientific research that is essential for planning the necessary measures. Products containing the non-intoxicating substance CBD in particular are gaining importance. Unauthorised use of cannabis or cannabis-containing products with an average of at least 1. Alongside hemp flowers and powder, cannabis products include other processed products like extracts oils and pastes , capsules sold in bulk and ready-to-use products such as food supplements, liquids for e-cigarettes, tobacco substitutes, aromatic oils, chewing gum and ointments, some of which are offered as toiletries. Recently, the production and sale of low-THC cannabis products have increased considerably and raise various health and legal issues. While these products are not subject to the Narcotics Act, they can nonetheless not be sold and advertised at will. Hemp plants contain more than 80 cannabinoids and over other active substances. CBD is not subject to the Narcotics Act, see above. The range is growing rapidly, and demand is increasing. Areas up for discussion include the possible therapeutic effects such as anti-oxidative, anti-inflammatory, anti-convulsive, anti-emetic, anxiolytic and anti-psychotic effects. However, there is currently insufficient research on the medicinal effect of CBD see also Medical use of cannabis. Swissmedic: Questions on delimitation. Since , cannabis use by adults may be punished with a fixed penalty of CHF By contrast, possession of up to 10 g of cannabis for personal use is not considered a criminal offence. However, the Juvenile Criminal Law Act applies to minors. The aim of the fixed penalty procedure was to standardise prosecution of all cannabis users in Switzerland and reduce administrative and legal costs. This aim has only partly been achieved, as there are still considerable differences between cantons regarding implementation of the fixed penalty procedure. While THC is responsible for the intoxicating effect of cannabis, CBD does not have a psychoactive effect and is therefore not covered by the Narcotics Act. Use is particularly widespread among adolescents and young adults. One in ten adolescents aged between 15 and 24 has smoked cannabis within the last month. Use decreases with age and becomes a niche phenomenon. For years, the level of cannabis use among adolescents in Switzerland has been among the highest in Europe. It is encouraging that the number of students who have consumed cannabis has declined significantly since In addition, most young people only consume it from time to time and then give it up completely after a certain period. High levels of use and long-term use are associated with a greater incidence of critical life problems, associated with serious developmental disorders, social disintegration and subsequent addiction. In general, however, adolescents who experiment with cannabis over a limited period of time and in small amounts exhibit normal, well-adjusted psychosocial development. It is therefore incorrect to refer to cannabis as a youth problem. However, it is indeed a youth phenomenon. Cannabis Examination of cannabis for extenders, blends, pesticides, microbiological and inorganic contaminations in German PDF, 2 MB, Evidence-based and impact-oriented cannabis prevention. Overall concept for protection of health for the pilot trials with cannabis Curia Vista Cannabis Policy - The questions no one asks in French. Last modification Print contact. Homepage Main navigation Content area Sitemap Search. Contact information. Cannabis as a narcotic drug As a psychoactive substance, cannabis is smoked, with or without tobacco, as marijuana dried flower heads or hashish resin from the flower heads. Health risks of cannabis use From a public health perspective, frequent use of large amounts of cannabis over a long period is particularly problematic. What is the FOPH doing to address cannabis use? Low-THC Cannabis Unauthorised use of cannabis or cannabis-containing products with an average of at least 1. Legislation Further information Research reports on Cannabis Here a list of research reports on the topic 'Cannabis' that have been funded by the Federal Office of Public Health. Addiction counseling and therapy. National Strategy on Addiction The National Strategy on Addiction aims to prevent the development of addiction, provide help to people with an addiction and reduce the negative impact on health and society.

Switzerland buying marijuana